May 19, 2020 / 11:56 AM / 7 days ago

BRIEF-Biogen Inc Announces New Data From Multiple Sclerosis Treatment Portfolio

May 19 (Reuters) - Biogen Inc:

* BIOGEN INC - ANNOUNCED NEW DATA FROM MULTIPLE SCLEROSIS TREATMENT PORTFOLIO

* BIOGEN - ADDITIONAL CLINICAL DATA SUPPORT VUMERITY AS AN IMPORTANT ORAL TREATMENT OPTION IN RELAPSING MS

* BIOGEN INC - ADDITIONAL CLINICAL DATA REINFORCE EFFICACY OF TECFIDERA Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below